Analyst consensus rating
Tango Therapeutics Analyst Rating: Strong Buy
Direct answer
Tango Therapeutics's consensus rating is Strong Buy.
11 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $47.00.
Forecast evidence checked November 18, 2026.
Get free Tango Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $22.11
- Average price target
- $47.00
- High price target
- $68.00
- Low price target
- $24.00
- Low target gap
- +8.5%
- Target upside
- +112.6%
- High target gap
- +207.6%
- Target range width
- 199%
- Consensus rating
- Strong Buy
- Analysts
- 11
- Evidence date
- November 18, 2026
- Valid through
- November 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Tango Therapeutics?
Tango Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $47.00.
How far are Tango Therapeutics's low and high targets from the recorded price?
The low target implies +8.5%, while the high target implies +207.6%.
How many analysts are included in Tango Therapeutics's consensus?
The verified consensus includes 11 analysts.
How is Tango Therapeutics's target upside or downside calculated?
The average target of $47.00 is divided by the recorded price of $22.11, then one is subtracted to produce +112.6%. This does not guarantee a future return.
When was Tango Therapeutics's analyst forecast verified?
The data was verified on 2026-11-18. The dataset is valid through 2026-11-25.